News for Pliant Therapeutics, Inc. (PLRX)

On March 3, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a notable transaction by acquiring 5,859,044 shares of Pliant Therapeutics Inc (PLRX)

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across multiple tumor types PLN-101095 was gener

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. ( PLRX) today announced that its Board of Directors has unanimously

Massachusetts-based 2seventy bio, Inc. (TSVT), a cell and gene therapy company is up over 76 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Massachusetts-based 2seventy bio, Inc. (TSVT), a cell and gene therapy company is up over 76 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Significant Transaction by FMR LLC (Trades, Portfolio) On February 28, 2025, FMR LLC (Trades, Portfolio) executed a notable transaction involving Pliant Therape

PR NewswireNEW YORK, March 4, 2025 NEW YORK, March 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeut

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Discontinuation of BEACON-IPF following DSMB and outside expert panel recommendation SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant T

**media[556085]**

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeu

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. ( PLRX) today announced that following a prespecified data review an

**media[555774]**

PR NewswireNEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeut

PR NewswireNEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeu

On December 31, 2024, Redmile Group, LLC (Trades, Portfolio), a prominent investment firm, executed a significant transaction involving Pliant Therapeutics Inc

Overview of the Recent Transaction On December 31, 2024, Blue Owl Capital Holdings LP (Trades, Portfolio) executed a significant transaction by acquiring an add

Overview of the Recent Transaction On December 31, 2024, Blue Owl Capital Holdings LP (Trades, Portfolio) executed a significant transaction involving AEON Biop

On December 31, 2024, Blue Owl Capital Holdings LP (Trades, Portfolio) made a significant move by acquiring 554,250 shares of Marker Therapeutics Inc (MRKR). Th